LMOD2 p.Pro443Leu
c.1328C>T · VCV4623742
Computational evidence
| Protein change | ||
| AlphaMissense | 0.1027 | likely benign |
|---|---|---|
| REVEL | 0.254 | benign-leaning |
| SaProt | LLR -10.41 | damaging |
| ⇒ SaProt calls this damaging; AlphaMissense and REVEL do not. | ||
| Splicing | ||
| SpliceAI | <0.2 | no splice effect predicted · four deltas, not one · how we know |
| Constraint at this position | ||
| Conservation | phyloP 4.4 | GERP 2.1, phastCons 1 |
| Regional constraint | o/e 0.93 | unconstrained · MANE · 7,778 bp · p 0.09 · regional, not allelic |
| Overall | ||
| CADD | 21.2 | PHRED · no single calibrated threshold — expert panels disagree |
AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.
Population frequency
Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.
Variant & gene context
- Gene
- LMOD2
- Protein
- p.Pro443Leu
- Coding
- c.1328C>T
- MANE Select
- NM_207163
- Type
- single nucleotide variant
- Location
- chr7:123662914 (GRCh38)
- Gene constraint
- LOEUF 0.984 · pLI <0.01 (gnomAD)
- Structure
- AlphaFold pLDDT 67.14 · 6 PDB
- Residue 443
- a UniProt-annotated variant site (in cmd2g; no protein detected by western blot in cardiac tissue from a homozygous patient); the 'interaction with actin 2' region; the 'disordered' region
Similar variants
- LMOD2 p.Pro443= Likely benign ★ same residue
- LMOD2 p.Arg231Cys Uncertain significance ★★ ⚠ same condition
- LMOD2 p.Glu276Lys Uncertain significance ★★ ⚠ same condition
- LMOD2 p.Thr244Met Uncertain significance ★★ ⚠ same condition
- LMOD2 p.Ala23Ser Uncertain significance ★ same condition
- LMOD2 p.Ala23Val Uncertain significance ★ ⚠ same condition
- LMOD2 p.Ala287Pro Uncertain significance ★ ⚠ same condition
- LMOD2 p.Ala287Thr Uncertain significance ★ ⚠ same condition
Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →
Cite Sugi Variant
Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/lmod2-p-pro443leu (accessed [today's date]).
Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown